Subcortical laminar heterotopia
Subcortical laminar heterotopia (SLH), also known as band heterotopia, is a rare neurological disorder characterized by the abnormal location of neuronal brain cells. In individuals with SLH, bands of gray matter are found in inappropriate locations within the white matter of the brain, rather than being properly positioned in the cerebral cortex. This condition is a form of neuronal migration disorder, which occurs during the development of the fetus when neurons do not reach their intended destinations in the brain.
Causes[edit | edit source]
Subcortical laminar heterotopia is most commonly caused by mutations in the FLNA gene, which provides instructions for producing filamin A, a protein involved in the development and maintenance of cell shape and movement. The FLNA gene mutations that cause SLH disrupt the normal migration of neurons during brain development. This disorder is inherited in an X-linked dominant manner, meaning that a mutation in one of the two copies of the gene in each cell is sufficient to cause the disorder in females, and a single mutation in males (who have only one X chromosome) will cause the disorder. However, due to the severity of the mutation, males are often more severely affected and may not survive pregnancy.
Symptoms[edit | edit source]
The symptoms of subcortical laminar heterotopia can vary widely among affected individuals. Common symptoms include epilepsy, which is the most prevalent symptom, intellectual disability, and developmental delay. The severity of these symptoms can range from mild to severe. Some individuals may have normal intelligence and only present with seizures, while others may have significant developmental and intellectual disabilities.
Diagnosis[edit | edit source]
Diagnosis of subcortical laminar heterotopia is primarily based on magnetic resonance imaging (MRI) of the brain, which can reveal the characteristic bands of misplaced gray matter. Genetic testing can confirm a diagnosis by identifying mutations in the FLNA gene.
Treatment[edit | edit source]
There is no cure for subcortical laminar heterotopia, and treatment focuses on managing symptoms. Antiepileptic drugs (AEDs) are commonly used to control seizures. In some cases, surgery may be considered to remove focal areas of the brain that are causing seizures, but this is not always possible or effective due to the widespread nature of the brain abnormalities in SLH. Early intervention programs and special education services can help individuals with developmental delays and intellectual disabilities to reach their full potential.
Prognosis[edit | edit source]
The prognosis for individuals with subcortical laminar heterotopia varies depending on the severity of the symptoms. While some individuals may lead relatively normal lives with appropriate treatment for seizures and developmental support, others may have significant disabilities. Lifespan can also vary, with some individuals living into adulthood with proper management of their condition.
50px This neurological disorder related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD